HealthCare Global Enterprises Limited (NSE:HCG)
632.60
+6.90 (1.10%)
Jun 17, 2026, 12:08 PM IST
NSE:HCG Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, NSE:HCG stock has a consensus rating of "Strong Buy" and an average price target of ₹779.56. The average 1-year stock price forecast is 23.23% higher than the current stock price, while the lowest is ₹724.00 (+14.45%) and the highest is ₹920.00 (+45.43%).
Price Target: ₹779.56 (+23.23%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 27, 2026.
Analyst Ratings
The average analyst rating for NSE:HCG stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 7 | 8 | 9 |
| Buy | 2 | 3 | 3 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 8 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst ICICI Securities No rating | ICICI Securities | Buy Maintains ₹710.00 | Buy | Maintains | ₹710.00 | +12.24% | Feb 27, 2026 |
| Geojit Research | Geojit Research | Buy Upgrades ₹724.00 | Buy | Upgrades | ₹724.00 | +14.45% | Feb 19, 2026 |
Unknown Analyst Axis Direct No rating | Axis Direct | Buy Maintains ₹750.00 | Buy | Maintains | ₹750.00 | +18.56% | Feb 10, 2026 |
Financial Forecast
Revenue This Year
29.11B
from 25.45B
Increased by 14.35%
Revenue Next Year
33.35B
from 29.11B
Increased by 14.60%
EPS This Year
8.72
from 3.59
Increased by 142.83%
EPS Next Year
14.32
from 8.72
Increased by 64.20%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 30.1B | ||
| Avg | 29.1B | ||
| Low | 28.2B |
Revenue Growth
| Revenue Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 18.3% | ||
| Avg | 14.3% | ||
| Low | 10.7% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | - | ||
| Avg | 8.72 | ||
| Low | - |
EPS Growth
| EPS Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | - | ||
| Avg | 142.8% | ||
| Low | - |